Roche完成了美国Poseida生物制药公司15亿美元的收购,以促进生物制药研发。 Roche finalizes $1.5 billion acquisition of U.S. biopharma firm Poseida to boost biopharmaceutical R&D.

Roche是一家主要的制药公司,它将以15亿美元完成对美国Poseida生物制药公司的收购。 Roche, a leading pharmaceutical company, will finalize its acquisition of U.S. biopharma firm Poseida for $1.5 billion. 这项交易旨在加强Roche在生物制药方面的研究和开发能力。 This deal aims to enhance Roche's research and development capabilities in biopharmaceuticals.